20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

LL-37 and Innate Immunity: A Deeper Look at Host Defense Mechanisms

NINGBO INNO PHARMCHEM CO.,LTD. is committed to unraveling the complexities of the human immune system, with a particular interest in the signaling and effector functions of antimicrobial peptides. Among these, LL-37, the human cathelicidin, stands out for its vital role in innate immunity. Understanding LL-37 in innate immunity is fundamental to appreciating its contribution to host defense.

LL-37 is a highly versatile peptide that acts as a frontline defender against a broad spectrum of pathogens. It is produced by various cells, including neutrophils and epithelial cells, and is released at sites of infection or injury. Its primary function is antimicrobial, achieved through mechanisms such as membrane disruption, which is intricately linked to its structural properties. The peptide's amphipathic alpha-helical nature enables it to interact with and permeabilize bacterial membranes, a process often involving LL-37 channel formation.

Beyond direct pathogen killing, LL-37 plays significant immunomodulatory roles. It can attract immune cells to infection sites, influence the release of cytokines, and promote wound healing. These functions highlight its importance in orchestrating the body's response to threats. The study of LL-37 structure-activity relationship is crucial for understanding how these various activities are mediated and how they can be therapeutically modulated.

The broad applicability of LL-37 is being explored in numerous research areas. Its potential in combating antibiotic-resistant bacteria is a major focus, offering a new avenue in the face of dwindling conventional antibiotic options. Furthermore, its involvement in inflammatory skin conditions like psoriasis and its role in tissue repair are areas of intense investigation. The insights gained from studying the LL-37 antimicrobial peptide mechanism are continuously expanding our knowledge of host defense.

NINGBO INNO PHARMCHEM CO.,LTD. is proud to contribute to the growing body of knowledge surrounding LL-37. By investigating its fundamental properties and therapeutic potential, we aim to develop innovative solutions that leverage the power of innate immunity to address critical health challenges. The intricate mechanisms of LL-37 offer a promising glimpse into the future of medicine.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: LL-37: A New Era in Combating Antibiotic Resistance

Next: The Structural Secrets of LL-37: From Channel Formation to Therapeutic Design

All Rights Reserved